1-4 of 4
Henrik Agerso
Close
Sort by
Journal Articles

A Population Pharmacokinetic Model for Concizumab Based on Phase 1 and Phase 2 Trial Data

Trine Høyer Rose, PhD, Christian Hollensen, MSc, PhD, Henrik Agersø, DVM, PhD, Rune Viig Overgaard, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 4.
https://doi.org/10.1182/blood-2020-140255
Published: 2020
Journal Articles

Modulating the Antithrombin-Mediated in Vivo Clearance of Coagulation Factor VIIa

Henrik Østergaard, PhD, Lene Hansen, Hermann Pelzer, PhD, Henrik Agersø, Anette A. Pedersen, Tina H. Glue, Laust B. Johnsen, PhD, Gorm Andersen, Jais R. Bjelke, Jens Breinholt, Henning Stennicke, MSc, PhD, Prafull S. Gandhi, PhD, Ole H. Olsen, PhD, Mette B. Hermit
Journal: Blood
Blood (2014) 124 (21): 4233.
https://doi.org/10.1182/blood.V124.21.4233.4233
Published: 2014
Journal Articles

Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide

Henrik Østergaard, Jais R. Bjelke, Lene Hansen, Lars Christian Petersen, Anette A. Pedersen, Torben Elm, Flemming Møller, Mette B. Hermit, Pernille K. Holm, Thomas N. Krogh, Jørn M. Petersen, Mirella Ezban, Brit B. Sørensen, Mette D. Andersen, Henrik Agersø, Haleh Ahmadian, Kristoffer W. Balling, Marie Louise S. Christiansen, Karin Knobe, Timothy C. Nichols, Søren E. Bjørn, Mikael Tranholm
Journal: Blood
Blood (2011) 118 (8): 2333–2341.
https://doi.org/10.1182/blood-2011-02-336172
Published: 2011
Includes: Supplemental data
Journal Articles

Formation of FVIIa-Antithrombin Complexes After Administration of rFVIIa to Hemophilia Patients.

Mirella Ezban, PhD, Erika Martin, MT, (ASCP), John Christian Barrett, MD, Janice Kuhn, RN, Mindy Nolte, Hermann Pelzer, Henrik Agerso, Lars Christian Petersen, Ulla Hedner, MD, PhD, Marcus E. Carr, Jr., MD, PhD, Donald Brophy, Pharm.D.
Journal: Blood
Blood (2009) 114 (22): 1295.
https://doi.org/10.1182/blood.V114.22.1295.1295
Published: 2009